Canada Markets close in 2 hrs 8 mins

H-CYTE, Inc. (HCYT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0200+0.0004 (+2.05%)
As of 03:06PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.0195
Open0.0171
BidN/A x N/A
AskN/A x N/A
Day's Range0.0171 - 0.0200
52 Week Range0.0171 - 93.8000
Volume114,260
Avg. Volume40
Market Cap3.259M
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)-0.0410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    H-CYTE Announces 1-for-1,000 Reverse Stock Split

    Strategic Decision to Support Improved Investor Profile and Potential Future Uplisting of Securities to Major ExchangeTAMPA, Fla., June 13, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that the Board approved a 1-for-1,000 reverse stock split, effective 9:30 a.m. on Monday, June 13, 2022. The Company’s common stock will open for trading on the OTC Exchange on Monday, June 13, 2022 on a split-adjusted basis under the current trading symbol "H

  • GlobeNewswire

    H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise

    Proceeds to Support Inorganic Growth and General Working Capital PurposesTAMPA, Fla., March 04, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, announced today that it has received $1,053,605 from the exercise of 75,257,511 previously issued warrants. The funds received will be used to fund the Company’s transition to a hybrid-biopharmaceutical company through strategic acquisitions, as well as for general working capital purposes. In connection with the exerc

  • GlobeNewswire

    H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc.

    Targets one of Healthcare’s Largest Multi-Billion Dollar Markets: Cardiac ElectrophysiologyTAMPA, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that it has entered into a letter of intent for the acquisition of Catheter Precision, Inc. Catheter Precision is a medical device company focused on one of healthcare’s largest multi-billion dollar markets: Cardiac Electrophysiology. Catheter Precision has developed two cost-effective,